News
AGMB
14.06
-5.32%
-0.79
Agomab Proposes New Board Members and Plans Warrant Adjustment Ahead of September 11 Meetings
TipRanks · 2d ago
Agomab Announces Proposed Appointments of Marino Garcia and Dr. Naimish Patel to Board of Directors
Barchart · 2d ago
Morgan Stanley Sticks to Their Buy Rating for AgomAb Therapeutics NV ADR (AGMB)
TipRanks · 2d ago
Weekly Report: what happened at AGMB last week (0803-0807)?
Weekly Report · 2d ago
AgomAb Therapeutics NV reports 1H results
Seeking Alpha · 5d ago
Agomab Posts Half-Year 2026 Results, Advances Fibro-Inflammation Pipeline After Nasdaq IPO
TipRanks · 6d ago
We Think AgomAb Therapeutics (NASDAQ:AGMB) Can Afford To Drive Business Growth
Simply Wall St · 08/05 11:02
Analysts Offer Insights on Healthcare Companies: Wave Life Sciences (WVE), BrightSpring Health Services, Inc. (BTSG) and AgomAb Therapeutics NV ADR (AGMB)
TipRanks · 08/03 12:50
Weekly Report: what happened at AGMB last week (0727-0731)?
Weekly Report · 08/03 10:32
Weekly Report: what happened at AGMB last week (0720-0724)?
Weekly Report · 07/27 10:38
Agomab initiated with a Buy at B. Riley
TipRanks · 07/23 12:26
Analysts’ Top Healthcare Picks: AgomAb Therapeutics NV ADR (AGMB), Milestone Pharmaceuticals (MIST)
TipRanks · 07/23 08:00
Weekly Report: what happened at AGMB last week (0713-0717)?
Weekly Report · 07/20 10:33
Weekly Report: what happened at AGMB last week (0706-0710)?
Weekly Report · 07/13 10:35
Rare Stock Picks In June 2026 - From 19 Discerning Analysts
Seeking Alpha · 07/06 12:00
Weekly Report: what happened at AGMB last week (0629-0703)?
Weekly Report · 07/06 10:40
Agomab Therapeutics NV trading resumes
TipRanks · 06/29 20:00
Agomab Therapeutics NV trading halted, volatility trading pause
TipRanks · 06/29 19:56
Weekly Report: what happened at AGMB last week (0622-0626)?
Weekly Report · 06/29 10:34
Agomab Details NOV-ERA Phase 2b Trial Design for Ontunisertib in Fibrostenosing Crohn’s Disease
TipRanks · 06/23 21:07
More
Webull provides a variety of real-time AGMB stock news. You can receive the latest news about AgomAb Therapeutics NV through multiple platforms. This information may help you make smarter investment decisions.
About AGMB
Agomab Therapeutics NV is a Belgium-based company. The Company is engaged in research and development services creating therapies for fibrotic and inflammatory diseases. Its activities include discovery research to identify drug candidates that act on pathways involved in fibrosis and tissue repair, such as organ restricted small molecules and growth factor targeting antibodies. The Company also carries out preclinical development, including work on programs, to evaluate drug behavior and readiness before entering human studies. In addition, It conducts clinical development services by sponsoring and managing trials for its pipeline, assessing safety, tolerability, pharmacokinetics, and pharmacodynamics.